Arizona Heart Institute pioneers research that may offer new hope to heart failure patients (35313_300k.wmv)

Nationally, over 3,000 people are waiting for a heart transplant – and a new lease on life. Sadly, only half of those will receive a transplant. Now, pioneering research at Arizona Heart Institute (AHI) is paving the way for how to treat congestive heart failure (CHF) patients.

Called MyoCell® Muscle Stem Cell Therapy, the unique transplant procedure actually uses skeletal muscle stem cells (myoblasts) from the patient’s own body that are injected into the heart. This may create new functioning heart muscle.

To view Multimedia News Release, go to http://www.prnewswire.com/mnr/ahi/35313/